| Barbara Joy Foner, MD MPH FCCP ABSM | |
|
6812 State Rte 162 Suite 202, Maryville, IL 62062 | |
| (618) 288-6844 | |
| (618) 288-6852 |
| Full Name | Barbara Joy Foner |
|---|---|
| Gender | Female |
| Speciality | Critical Care (intensivists) |
| Experience | 35 Years |
| Location | 6812 State Rte 162 Suite 202, Maryville, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437141090 | NPI | - | NPPES |
| 1437141090 | Medicaid | MO |
| Facility Name | Location | Facility Type |
|---|---|---|
| Anderson Hospital | Maryville, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anderson Medical Group Llc | 5193792018 | 120 |
News Archive
Too little covid vaccine and too great a demand: That's what KHN readers from around the country detail in their often exasperating quest to snag a shot, although they are often clearly eligible under their local guidelines and priority system.
This new study, which exposed pregnant rodents to a range of BPA dietary doses from low to high, concluded that BPA had no effects on brain development or behavior in their offspring that had been exposed to BPA in utero and throughout development. The robust study was conducted by highly qualified researchers at WIL Research Laboratories.
Morphotek, Inc., a subsidiary of Eisai Inc., today announced that a monoclonal antibody has been selected for advancement to clinical development under the terms of its March 2009 collaboration agreement with Human Genome Sciences, Inc.
Several vaccines have been rapidly developed to help control the COVID-19 pandemic, including the BNT162b2 vaccine (Pfizer/BioNTech). This severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine has been shown in both clinical trials and in the real world to be highly efficacious in preventing infection, symptoms, hospitalizations, severe disease, and death related to coronavirus disease (COVID-19).
More than 50% of individuals with moderate kidney disease have hypertension that is resistant to medications, and those who are black or have a larger waist circumference, diabetes, or a history of heart attacks or strokes are at highest risk, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
› Verified 4 days ago
| Entity Name | Anderson Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700807716 PECOS PAC ID: 5193792018 Enrollment ID: O20040910001137 |
News Archive
Too little covid vaccine and too great a demand: That's what KHN readers from around the country detail in their often exasperating quest to snag a shot, although they are often clearly eligible under their local guidelines and priority system.
This new study, which exposed pregnant rodents to a range of BPA dietary doses from low to high, concluded that BPA had no effects on brain development or behavior in their offspring that had been exposed to BPA in utero and throughout development. The robust study was conducted by highly qualified researchers at WIL Research Laboratories.
Morphotek, Inc., a subsidiary of Eisai Inc., today announced that a monoclonal antibody has been selected for advancement to clinical development under the terms of its March 2009 collaboration agreement with Human Genome Sciences, Inc.
Several vaccines have been rapidly developed to help control the COVID-19 pandemic, including the BNT162b2 vaccine (Pfizer/BioNTech). This severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine has been shown in both clinical trials and in the real world to be highly efficacious in preventing infection, symptoms, hospitalizations, severe disease, and death related to coronavirus disease (COVID-19).
More than 50% of individuals with moderate kidney disease have hypertension that is resistant to medications, and those who are black or have a larger waist circumference, diabetes, or a history of heart attacks or strokes are at highest risk, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
› Verified 4 days ago
| Entity Name | Midwest Emergency Anderson Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710647615 PECOS PAC ID: 8022401256 Enrollment ID: O20220210000357 |
News Archive
Too little covid vaccine and too great a demand: That's what KHN readers from around the country detail in their often exasperating quest to snag a shot, although they are often clearly eligible under their local guidelines and priority system.
This new study, which exposed pregnant rodents to a range of BPA dietary doses from low to high, concluded that BPA had no effects on brain development or behavior in their offspring that had been exposed to BPA in utero and throughout development. The robust study was conducted by highly qualified researchers at WIL Research Laboratories.
Morphotek, Inc., a subsidiary of Eisai Inc., today announced that a monoclonal antibody has been selected for advancement to clinical development under the terms of its March 2009 collaboration agreement with Human Genome Sciences, Inc.
Several vaccines have been rapidly developed to help control the COVID-19 pandemic, including the BNT162b2 vaccine (Pfizer/BioNTech). This severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine has been shown in both clinical trials and in the real world to be highly efficacious in preventing infection, symptoms, hospitalizations, severe disease, and death related to coronavirus disease (COVID-19).
More than 50% of individuals with moderate kidney disease have hypertension that is resistant to medications, and those who are black or have a larger waist circumference, diabetes, or a history of heart attacks or strokes are at highest risk, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
› Verified 4 days ago
| Entity Name | Midwest Inpatient Anderson Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821758608 PECOS PAC ID: 3072908474 Enrollment ID: O20220322002045 |
News Archive
Too little covid vaccine and too great a demand: That's what KHN readers from around the country detail in their often exasperating quest to snag a shot, although they are often clearly eligible under their local guidelines and priority system.
This new study, which exposed pregnant rodents to a range of BPA dietary doses from low to high, concluded that BPA had no effects on brain development or behavior in their offspring that had been exposed to BPA in utero and throughout development. The robust study was conducted by highly qualified researchers at WIL Research Laboratories.
Morphotek, Inc., a subsidiary of Eisai Inc., today announced that a monoclonal antibody has been selected for advancement to clinical development under the terms of its March 2009 collaboration agreement with Human Genome Sciences, Inc.
Several vaccines have been rapidly developed to help control the COVID-19 pandemic, including the BNT162b2 vaccine (Pfizer/BioNTech). This severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine has been shown in both clinical trials and in the real world to be highly efficacious in preventing infection, symptoms, hospitalizations, severe disease, and death related to coronavirus disease (COVID-19).
More than 50% of individuals with moderate kidney disease have hypertension that is resistant to medications, and those who are black or have a larger waist circumference, diabetes, or a history of heart attacks or strokes are at highest risk, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Barbara Joy Foner, MD MPH FCCP ABSM 6812 State Rte 162 Suite 202, Maryville, IL 62062 Ph: (618) 288-6844 | Barbara Joy Foner, MD MPH FCCP ABSM 6812 State Rte 162 Suite 202, Maryville, IL 62062 Ph: (618) 288-6844 |
News Archive
Too little covid vaccine and too great a demand: That's what KHN readers from around the country detail in their often exasperating quest to snag a shot, although they are often clearly eligible under their local guidelines and priority system.
This new study, which exposed pregnant rodents to a range of BPA dietary doses from low to high, concluded that BPA had no effects on brain development or behavior in their offspring that had been exposed to BPA in utero and throughout development. The robust study was conducted by highly qualified researchers at WIL Research Laboratories.
Morphotek, Inc., a subsidiary of Eisai Inc., today announced that a monoclonal antibody has been selected for advancement to clinical development under the terms of its March 2009 collaboration agreement with Human Genome Sciences, Inc.
Several vaccines have been rapidly developed to help control the COVID-19 pandemic, including the BNT162b2 vaccine (Pfizer/BioNTech). This severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine has been shown in both clinical trials and in the real world to be highly efficacious in preventing infection, symptoms, hospitalizations, severe disease, and death related to coronavirus disease (COVID-19).
More than 50% of individuals with moderate kidney disease have hypertension that is resistant to medications, and those who are black or have a larger waist circumference, diabetes, or a history of heart attacks or strokes are at highest risk, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
› Verified 4 days ago
Dr. Christopher Farrar, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 6800 State Route 162, Maryville, IL 62062 Phone: 618-288-4095 Fax: 618-288-2984 | |
Syed M Arshad, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2227 Vadalabene Dr, Suite 100, Maryville, IL 62062 Phone: 618-288-1140 | |
Dr. Sajid Mehmood, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 6800 State Route 162, Maryville, IL 62062 Phone: 618-288-5711 Fax: 618-288-4088 | |
Dr. Rafe M Heng, D.O., FACC Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 6812 State Rte 162 Suite 202, Maryville, IL 62062 Phone: 618-288-1748 Fax: 618-288-1768 | |
Dr. Saulat Mushtaq, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2227 Vadalabene Dr, Maryville, IL 62062 Phone: 618-391-5046 Fax: 618-391-5049 | |
Sujata Sitaula, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2133 Vadalabene Dr Ste 1, Maryville, IL 62062 Phone: 618-288-4350 Fax: 618-288-4296 |